NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹2.48 Cr | ₹2.19 Cr | ₹1.37 Cr | ₹1.91 Cr | ₹2.38 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NGL FINECHEM ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹2.48 Cr |
Mar2024 | ₹2.19 Cr |
Mar2023 | ₹1.37 Cr |
Mar2022 | ₹1.91 Cr |
Mar2021 | ₹2.38 Cr |
How is Deferred Tax Assets / Liabilities of NGL FINECHEM Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹2.48 Cr | 12.85 | |
Mar2024 | ₹2.19 Cr | 60.15 | |
Mar2023 | ₹1.37 Cr | -28.20 | |
Mar2022 | ₹1.91 Cr | -19.76 | |
Mar2021 | ₹2.38 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹873.6 Cr | -2.1% | 13.3% | -33.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3.3% | -6.9% | -9.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | 1.7% | -6.8% | 25.4% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.9% | 0.5% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -1.9% | -1.3% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,408.0 Cr | -1.2% | -2% | -9% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -2.1% |
13.3% |
-33.9% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses